Previous post Next post

Novartis CEO wants to end higher pricing for drugs sold in the US

Swissinfo by
Swissinfo
My articles My siteAbout meMy videosMy books
Follow on:TwitterFacebookGoogle +
The Swiss pharmaceutical company Novartis wants to eliminate the price difference between medicines in the US and other industrialised countries. Group CEO Vasant Narasimhan believes that countries outside the US have a duty to contribute more to innovation. "It is a fact that American patients pay for a large part of the innovations," said Narasimhan in an interview with the Neue Zürcher Zeitung published on Saturday. +Get the most important news from Switzerland in your inbox The background to this is American President Donald Trump's demand for price cuts. At the beginning of August, he gave Swiss companies such as Roche and Novartis, among others, a 60-day deadline to reduce their prices. This represents a challenge worth billions for the companies. Novartis is working with the government and trying to find "constructive solutions so that Americans have to pay less for their medicines", said the CEO. Swiss prices are 'far too low' When asked what this means for Switzerland ... Full story here Are you the author?
About Swissinfo
Swissinfo
SWI swissinfo.ch – the international service of the Swiss Broadcasting Corporation (SBC). Since 1999, swissinfo.ch has fulfilled the federal government’s mandate to distribute information about Switzerland internationally, supplementing the online offerings of the radio and television stations of the SBC. Today, the international service is directed above all at an international audience interested in Switzerland, as well as at Swiss citizens living abroad.
My articlesMy siteAbout meMy books
Follow on:TwitterFacebookGoogle +

You Might Also Like

Swiss firm suspected of violating gold sanctions against Russia

2025-09-20

The State Secretariat for Economic Affairs (Seco) has launched an investigation into Open Mineral, a commodities trader based in Baar. The company is suspected of violating sanctions against Russia in relation to gold, Reuters reported on Friday. Open Mineral allegedly traded the precious metal from Russia, violating sanctions against Moscow after the start of the …

Continue reading »

Swiss Jura region hit hard by US tariffs

2025-09-18

The economy of the Jura region in western Switzerland is suffering as a result of the tariffs imposed by the United States. Since the beginning of September, more than 100 companies, employing a total of 4,000 people, have applied for short-time work compensation. This affects around 10% of the canton’s workforce. These figures are quoted …

Continue reading »

Switzerland launches trade alliance with 13 small and medium-sized economies

2025-09-16

Switzerland wants to diversify and strengthen trade relations together with 13 other countries. With this in mind, the small and medium-sized economies involved have launched the ‘Future of Investment and Trade Partnership’. The new initiative brings together small and medium-sized economies with an interest in open and rules-based global trade. According to the economics ministry, …

Continue reading »

Previous post See more for 3.) Swissinfo Business and Economy Next post
Tags: ,

Permanent link to this article: https://snbchf.com/2025/09/novartis-ceo-wants-higher-pricing-drugs/

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

This site uses Akismet to reduce spam. Learn how your comment data is processed.